The risk of second primary malignancy in patients with stage Ia non-small cell lung cancer: a U.S. population-based study-Reference-Cited by-同舟云学术

The risk of second primary malignancy in patients with stage Ia non-small cell lung cancer: a U.S. population-based study

Published:2017-10-23 Issue:2 Volume:57 Page:239-243
ISSN:0284-186X
Container-title:Acta Oncologica
language:en
Short-container-title:Acta Oncologica

Author:

Khanal Amit¹,Lashari Bilal Haider²^ORCID,Kruthiventi Sreechandralekha³,Arjyal Lubina⁴,Bista Amir⁴,Rimal Priya⁵,Uprety Dipesh⁶

Affiliation:

1. Department of Hematology and Oncology, University of Illinois at Chicago, Chicago, IL, USA;

2. Abington Memorial Hospital, Abington, PA, USA;

3. P.S.I. Medical College, Chinoutpalli, India;

4. Gundersen Health System, La Crosse, WI, USA;

5. Nepal Medical College Teaching Hospital, Kathmandu, Nepal;

6. Gundersen Health System, La Crosse, WI, USA

Publisher

Informa UK Limited

Subject

Radiology Nuclear Medicine and imaging,Oncology,Hematology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/0284186X.2017.1390250

Reference16 articles.

1. Cancer statistics, 2015

2. Lung cancer incidence statistics. Cancer Research UK Web site. Updated 2015 [cited 2017 Sep 12]. Available at: http://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/lung-cancer/incidence.

3. SEER cancer statistics review (CSR) 1975–2013. 2016 [cited 2017 Sep 12]. Available at: http://seer.cancer.gov/csr/1975_2013/.

4. Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening

5. National Cancer Institute Surveillance, Epidemiology, and End Results Program. 2017 [cited 2017 Sep 14]. Available at: https://seer.cancer.gov/about/overview.html.

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic analysis of lung squamous cell carcinoma patients with second primary malignancies: a SEER database study;Frontiers in Oncology;2024-02-20

2. Long term outcomes beyond 5 years after pulmonary resection for non-small-cell lung cancer;General Thoracic and Cardiovascular Surgery;2023-12-08

3. Risk-based screening for second primary extrapulmonary malignancies in stage I lung cancer patients: A study based on SEER database;Lung Cancer;2023-06

4. Treating with Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors (TKIs) Accompanying Lower Incidence of Second Primary Cancers;Journal of Clinical Medicine;2022-09-04

5. Triple primary lung cancer: a case report;BMC Pulmonary Medicine;2022-08-19